Writing Styles – Let’s hear it for…..the Tuatara
Those of you know me well (including those who wish they didn’t) will know that my heart and roots belong in New Zealand. Fortified by a large quantity of excellent…
Those of you know me well (including those who wish they didn’t) will know that my heart and roots belong in New Zealand. Fortified by a large quantity of excellent…
It is assumed that people make, or should make, rational choices based on self-interest. For conventional health economic evaluations, self-interest is approximated by individual preferences, such as maximum willingness-to-pay (WTP)…
Interview with Dr John Cai, a highly experienced economist and health economist with 20 years’ experience in both China and the US. John is a Senior Health Policy Analyst at the Massachusetts Executive Office of Health and Human Services in the U.S. heor.tv
Getting a drug approval, reimbursement, and access to markets is a long journey, but we are not alone. The focus on this year’s ISPOR EU annual conference was on health technology assessment in different countries. Is an international appraisal system likely in the near future?
George Bernard Shaw once described America and England as two countries separated by a common language. Might this also hold true for comparative effectiveness research and health technology assessment? This article highlights several, recently available resources for anyone seeking to understand healthcare systems outside their own country.
By Mary Gabb (mary.gabb@rxcomms.com) January 1, 2009 – typically a day of new beginnings – marked the beginning of the end of SWAG (stuff we all get, or freebies) for…
By David Woods (david.woods@rxcomms.com) Drug company Eli Lilly has said that it will start disclosing the amounts of money over $500 that it pays to physicians – and other firms…
By Mary Gabb (mary.gabb@rxcomms.com ) Since 1996, DTCA has existed only in the USA and New Zealand , but recent declarations from the European Commission (EC) suggest that the rules…
By David Woods (david.woods@rxcomms.com) Whether it’s because of a shortage of primary care physicians, impatience at the length of time it takes to see one, or simply increasing costs, the…
By Mary Gabb (mary.gabb@rxcomms.com) In a previous issue of HOC , we outlined some of the commonly expressed pros and cons of direct-to-consumer advertising (DTCA), which is currently allowed only…